Is pharmaceutical sponsorship of a dermatologic conference proper?

Authors
Citation
Ham. Neumann, Is pharmaceutical sponsorship of a dermatologic conference proper?, ARCH DERMAT, 135(6), 1999, pp. 645-646
Citations number
3
Categorie Soggetti
Dermatology,"da verificare
Journal title
ARCHIVES OF DERMATOLOGY
ISSN journal
0003987X → ACNP
Volume
135
Issue
6
Year of publication
1999
Pages
645 - 646
Database
ISI
SICI code
0003-987X(199906)135:6<645:IPSOAD>2.0.ZU;2-T
Abstract
When Alfred Hardy and his staff, which consisted of only a single person, o rganized the first International (World) Congress of Dermatology and Syphil ology at the Hopital Saint-Louis in August 1889 in Paris, France, it was a meeting of 220 scientists who sought to learn from each other by exchanging experiences and ideas. In those days, dermatology was medicine that was ba sed mainly on experience alone, although, even then, great dermatologists t ried to practice medicine predicated on evidence as well. As one example of that conflict in mentality, Wickham called attention to the fact that Page t disease of the nipple could be recognized morphologically as distinct fro m eczema. Despite his knowing that the process on the nipple was related to cancer, he nonetheless asserted that it was a parasitic disease, "since th e psorosperms could even be seen in the scales being shed."(l).